Verastem Oncology
is a Massachusetts-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer... Read moreVerastem Oncology
is a Massachusetts-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer... Read more
2010
PublicNASDAQVSTM
News
Jun 18, 2026
BioSpace
Verastem Oncology: Verastem deprioritizes pancreatic cancer work after 'decent, but not great' data shadowed by Revolution
Jun 17, 2026
Benzinga
Verastem Oncology: Verastem Stock Jumps As Data Shows Strong Survival Trends In Pancreatic Cancer
Jun 04, 2026
Yahoo
Verastem Oncology: VSTM Stock Climbs After-Hours As FDA Grants Fast Track To Lung Cancer Drug - Retail Eyes The Next Keytruda
May 27, 2026
Marketscreener
Verastem Oncology: Verastem Oncology to Present at Jefferies Healthcare Conference
May 12, 2026
Yahoo
Verastem Oncology: Verastem Oncology to Present at Upcoming Investor Conferences
May 09, 2026
Yahoo
Verastem Oncology: Verastem Q1 Earnings Call Highlights
May 08, 2026
Owler
Verastem, Inc.: Verastem Oncology's revenue changed from $30.91M in Dec 2025 to $49.59M in Mar 2026
May 07, 2026
Verastem
Press Release: Verastem Oncology : Verastem Oncology Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
Apr 30, 2026
StreetInsider
Press Release: Verastem Oncology : Verastem Oncology Launches HCP and Patient Reimagine Campaign to Increase Awareness of AVMAPKI FAKZYNJA CO-PACK for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer
Apr 10, 2026
Clinical Trials Arena
Verastem Oncology: Verastem Oncology's combo shows two-year durability in ovarian cancer
Verastem Oncology Competitors
1
2
3
4
5
6
7
8
9
10